Related Experiment Videos
Proto-oncogene expression in dermal naevi and melanomas
K Peris1, L Cerroni, S Chimenti
1Department of Dermatology, University of L'Aquila, Italy.
Archives of Dermatological Research
|January 1, 1991
Summary
Proto-oncogene messenger RNA (mRNA) expression, including c-myc and c-fos, was analyzed in skin lesions. Enhanced c-myc and c-fos mRNA levels were linked to the growth of melanocytic naevi and melanomas.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Proto-oncogenes (c-onc) are implicated in human neoplasia development.
- Understanding oncogene expression in melanocytic lesions is crucial for cancer research.
Purpose of the Study:
- To investigate the mRNA expression of c-myc, c-fos, c-neu (erb B-2), and Ha-ras in cutaneous melanocytic lesions and normal skin.
- To determine the role of these proto-oncogenes in the progression of naevi and melanomas.
Main Methods:
- Northern blot analysis was used to detect mRNA expression of c-myc, c-fos, c-neu, and Ha-ras.
- Quantitative densitometry was employed to measure mRNA expression levels in 12 melanocytic lesions and 5 normal skin samples.
Main Results:
- c-myc mRNA expression was higher in naevi than in melanomas.
- c-fos mRNA expression was significantly higher in melanomas compared to naevi.
- No significant differences in c-neu and Ha-ras mRNA levels were found between naevi and melanomas; c-neu mRNA was higher in normal skin.
Conclusions:
- Enhanced c-myc and c-fos mRNA expression may be important in the growth of melanocytic naevi and melanomas.
- Overexpression of c-fos could be involved in melanoma progression.
- Activation of Ha-ras and c-neu, indicated by mRNA overexpression, does not appear significant in cutaneous pigmented lesion progression.